Pharmacolog appoints Asal Attabipour as Director of QA-RA. Asal has a long experience of quality work in medical technology companies and will start her assignment on November 8, 2022.
In the role of Director of Quality Assurance and Regulatory Affairs (QA-RA), Asal will lead the company’s quality and certification work and act as PRRC (Person Responsible for Regulatory Compliance). She has a degree in biology from Mashad University in Iran and in toxicology from Karolinska Institutet. She has subsequently held several roles in global companies in development, operations and QA-RA. Previously, she has, among other things, functioned as Global Quality and Regulatory Affairs Specialist at Direct Health Care Group and Boule Medical as well as Regulatory Affairs Manager at Getinge AB. Asal will be part of the company’s management team and replaces current Director QA-RA Susanne Grimsby.
CEO Mats Högberg comments. “We are very happy that Asal has chosen to accept the role of Director of QA-RA. As we are facing an exciting phase with increased growth in several markets, we need an experienced person with experience in international quality work. I also want to take the opportunity to thank Susanne for an exceptionally good collaboration and wish her the best of luck in her new assignment.”
Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.